Main menu

MADISON, NJ--Last week's announced merger plans between American Home Products (AHP) here and Monsanto could be a signal that the powerful research and development technologies enabled by bio informatics and genomics are poised to transform the business landscape of the field of biotechnology.

The deal, valued at more than $34 billion, would create a company with operations in pharmaceuticals, agriculture, animal health, consumer healthcare, and nutrition with an estimated research budget of $3 billion.

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.